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Background. There is a need to better define the epidemiology of sepsis in intensive care units (ICUs) around the globe.
Methods. The Intensive Care over Nations (ICON) audit prospectively collected data on all adult (>16 years) patients admitted 
to the ICU between May 8 and May 18, 2012, except those admitted for less than 24 hours for routine postoperative surveillance. 
Data were collected daily for a maximum of 28 days in the ICU, and patients were followed up for outcome data until death, hospital 
discharge, or for 60 days. Participation was entirely voluntary.
Results. The audit included 10 069 patients from Europe (54.1%), Asia (19.2%), America (17.1%), and other continents (9.6%). 
Sepsis, defined as infection with associated organ failure, was identified during the ICU stay in 2973 (29.5%) patients, including 
in 1808 (18.0%) already at ICU admission. Occurrence rates of sepsis varied from 13.6% to 39.3% in the different regions. Overall 
ICU and hospital mortality rates were 25.8% and 35.3%, respectively, in patients with sepsis, but it varied from 11.9% and 19.3% 
(Oceania) to 39.5% and 47.2% (Africa), respectively. After adjustment for possible confounders in a multilevel analysis, independent 
risk factors for in-hospital death included older age, higher simplified acute physiology II score, comorbid cancer, chronic heart fail-
ure (New York Heart Association Classification III/IV), cirrhosis, use of mechanical ventilation or renal replacement therapy, and 
infection with Acinetobacter spp.
Conclusions. Sepsis remains a major health problem in ICU patients worldwide and is associated with high mortality rates. 
However, there is wide variability in the sepsis rate and outcomes in ICU patients around the globe.
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Sepsis is a major cause of morbidity and mortality in mod-
ern intensive care units (ICUs). Although several studies have 
provided epidemiological data on sepsis in ICU patients in 
the developed world [1–6], there is limited information on 
the global burden of sepsis worldwide [7, 8]. Yet, such data 
are crucially important to (1) increase awareness of the global 
impact of sepsis, (2) highlight the need for continued research 
into potential preventive and therapeutic interventions, and (3) 
help guide resource allocation [9]. Information on patterns of 
sepsis around the globe is also of interest, including causative 
microorganisms, primary source of infection, and associated 
outcomes.
In 2012, the World Federation of Societies of Intensive 
and Critical Care Medicine conducted a worldwide audit of 
data from ICUs around the world, providing a large data-
base from which to extract information. We used these data 
to explore the characteristics of patients with sepsis around 
the world, including international differences in occurrence 
rates, causative microorganisms, and outcomes. We also 
evaluated some factors associated with in-hospital mortality 
in these patients.
METHODS
The worldwide Intensive Care over Nations (ICON) audit 
recruited ICUs by open invitation, through national scientific 
societies, national and international meetings, e-mail lists, 
and individual contacts. Participation was entirely voluntary, 
with no financial incentive. Ethics committee approval was 
obtained by the participating institutions according to local 
ethical regulations. Informed consent was not required for this 
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observational and anonymous audit. Of the 730 ICUs contrib-
uting to the study from 84 countries (see the participants list 
in Appendix 1), 419 (57.4%) were in university/academic hos-
pitals. The organizational characteristics of these centers have 
been described previously [10].
Each ICU was asked to prospectively collect data on all adult 
(>16 years) patients admitted to their ICU between May 8 and 
May 18, 2012, except those who stayed in the ICU for <24 hours 
for routine postoperative surveillance. Readmissions of previ-
ously included patients were not included. Data were collected 
daily for a maximum of 28  days in the ICU. Outcome data 
were collected at the time of ICU and hospital discharge or at 
60 days. Data were entered anonymously using electronic case 
report forms via a secured internet-based website. Data collec-
tion on admission included demographic data and comorbidi-
ties. Clinical and laboratory data for simplified acute physiology 
(SAPS) II [11] and Acute Physiologic Assessment and Chronic 
Health Evaluation (APACHE) II [12] scores were reported 
as the worst values within the first 24 hours after admission. 
A  daily evaluation of organ function was performed accord-
ing to the sequential organ failure assessment (SOFA) score 
[13]; organ failure was defined as a SOFA subscore >2 for the 
organ in question. Clinical and microbiologic infections were 
reported daily as well as antimicrobial therapy.
Infection was defined according to the criteria of the 
International Sepsis Forum [14]. Sepsis was defined as the 
presence of infection with associated organ failure [15]. Septic 
shock was defined as sepsis associated with cardiovascular fail-
ure requiring vasopressor support (SOFA cardiovascular of 3 or 
4). Intensive care unit-acquired infection was defined as infec-
tion identified at least 48 hours after ICU admission. Non-ICU 
acquired infection was defined as infection present on admis-
sion or within the first 48 hours after ICU admission. Only the 
first episode of infection was considered in the analysis.
Detailed instructions and definitions were available through 
a secured website for all participants before starting data collec-
tion and throughout the study period. Any additional queries 
were answered on a per case basis. Validity checks were made 
at the time of electronic data entry, including plausibility checks 
within each variable and between variables. Data were further 
reviewed by the coordinating center for completeness and plau-
sibility, and any doubts were clarified with the participating 
center. There was no on-site monitoring. We did not attempt 
to verify the pathogenicity of the microorganisms, including 
the relevance of Staphylococcus epidermidis or the distinction 
between colonization and infection.
For the purposes of this audit, we divided the world into 8 
geographic regions: North America, South America, Western 
Europe, Eastern Europe, South Asia, East and Southeast Asia, 
Oceania, and Africa. Individual countries were also classified 
into 3 income groups according to the 2011 gross national 
income (GNI) per capita, calculated using the World Bank 
Atlas method [16]: GNI <$4035  =  low and lower middle 
income; GNI $4036–12 475 = upper middle income; and GNI 
>$12 476 = high income.
Statistical Analysis
Data are shown as means with standard deviation (SD), mean 
and 95% confidence intervals (CIs), medians and interquartile 
ranges (IQRs), numbers, and percentages. Differences between 
groups in distribution of variables were assessed using analysis 
of variance, Kruskal-Wallis test, Student’s t test, Mann-Whitney 
test, χ2 test, or Fisher’s exact test as appropriate.
To identify the risk factors associated with in-hospital mor-
tality in septic patients, we used a 3-level multilevel technique 
with the structure of an individual patient (level 1) admitted to 
a hospital (level 2) within a country (level 3). The explanatory 
variables considered in the model were as follows:
• Individual-level factors: age, sex, SAPS II score, type of 
admission, source of admission, mechanical ventilation or 
renal replacement therapy at any time during the ICU stay, 
comorbidities, onset of infection, site of infection, and the 
most common microorganisms
• Hospital-level factors: type of hospital; ICU specialty; total 
number of ICU patients in 2011; number of staffed ICU beds
• Country-level factors: GNI
Individual-level variables to be included in the final model were 
selected on the basis of a multilevel model including country-level 
and hospital-level factors and each of the individual-level fac-
tors; variables with P < .2 were considered in the final model. 
Collinearity between variables was checked by inspection of the 
correlation between them, by looking at the correlation matrix of 
the estimated parameters, and by looking at the change of param-
eter estimates and at their estimated standard errors (SEs) [17]. 
Q-Q plots were drawn to check for normality in the residuals. The 
results of fixed effects (measures of association) are given as odds 
ratios (ORs) with their 95% CIs and the 80% interval OR. Random 
effects (measures of variation) measures included the variance 
(var) and its SE and the median OR. The statistical significance of 
covariates was calculated using the Wald test.
Data were analyzed using IBM SPSS Statistics software, ver-
sion 22 for Windows and R software, version 2.0.1 (CRAN 
project). All reported P values are 2-sided, and P < .05 was con-
sidered to indicate statistical significance. The results of fixed 
effects are given as OR with 95% CIs.
RESULTS
Characteristics of the Study Group
A total of 10 069 patients were included in the audit; 2973 patients 
(29.5%) had sepsis, including 1808 (18.0%) with sepsis at admis-
sion to the ICU (Figure 1). In the whole cohort, antimicrobials 
were given to 5975 (59.3%) patients during their ICU stay. Patients 
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with sepsis were older, had higher severity scores on admission 
to the ICU, had more comorbidities, and were more commonly 
receiving mechanical ventilation and renal replacement therapy 
on admission to the ICU than patients without sepsis (Table 1). 
Patients with sepsis also had more organ failures than the other 
patients (median [IQ]: 3 [1–4] vs 1 [0–2] organs; P < .001).
Patterns of Infections
The most common source of sepsis was the respiratory tract 
(67.4%) followed by the abdomen (21.8%) (Supplementary 
Table E1). Positive isolates were retrieved in 69.6% (n = 2069) 
of patients with sepsis; two thirds of these patients had Gram-
negative microorganisms isolated and half had Gram-positive 
microorganisms; 1068 (51.6%) of the sepsis patients with posi-
tive isolates had more than 1 microorganism isolated (Table 2). 
Patients with urinary tract (82.6% vs 43.9%), abdominal (77.1% 
vs 50.8%), and respiratory tract (70.0% vs 51.4%) infections 
were more likely to have Gram-negative than Gram-positive 
isolates (Supplementary Table E1). Microbiological patterns 
varied around the globe (Table 2), with Gram-positive isolates 
being much less frequent (21.4%) in South Asia than in other 
regions. Methicillin-resistant Staphylococcus aureus (MRSA) 
was more common in the Middle East (14.4%) and North 
America (12.8%) than in Western Europe (6.1%). Klebsiella 
spp isolates were most commonly reported in Africa (31.3%), 
Eastern Europe (28.5%), and South America (24.7%), and 
Pseudomonas spp was most frequent in Eastern Europe (21.1%) 
and South America (20.4%). Fungal organisms contributed to 
14.5% and 14.8% of isolates in Western and Eastern Europe, 
respectively, but to only 5.1% of isolates in North America.
Patients with ICU-acquired infections (n  =  764) were 
younger, more likely to be surgical admissions, and had lower 
All admissions
N = 10 069
Sepsis
N = 1808 (18.0%)
Sepsis – no shock
N = 822 (8.2%)
Septic – shock
N = 986 (9.8%)
Septic shock
N = 1098 (10.9%)
Sepsis – no shock
N = 710 (7.1%)
Septic shock
N = 583 (5.8%)
Sepsis – no shock
N = 582 (5.8%)
Septic shock
N = 1681 (16.7%)
Sepsis – no shock
N = 1292 (12.8%)
No sepsis
N = 7096 (70.5%)
Sepsis
N = 1165 (11.6%)
No sepsis
N = 8261 (82.0%)
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Figure 1. Distribution of patients according to the presence or absence of sepsis on admission and during the intensive care unit (ICU) stay.
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SAPS II and SOFA scores on admission to the ICU, compared 
with those who had infections within the first 48 hours on 
the ICU (Table  3 and Supplementary Table E2). Respiratory 
and catheter-associated infections were more frequent and 
abdominal infections less frequent in patients with ICU-
acquired than in those with non-ICU-acquired infections 
(Supplementary Table E2). Patients with ICU-acquired infec-
tions were more likely to have positive isolates than patients 
with non-ICU-acquired infections (79.5% vs 66.2%, P < .001) 
(Supplementary Table E3).
Outcomes
Intensive care unit mortality rates were 25.8% in patients with 
sepsis and 12.1% in those without (P < .001); hospital mortal-
ity rates were 35.3% vs 16.7%, P  <  .001). Intensive care unit 
and hospital mortality rates varied from 11.9% and 19.3% 
(Oceania) to 39.5% and 47.2% (Africa), respectively (Table 2). 
Intensive care unit length of stay was longer (6 [3–13] vs 2 [1–4] 
days, P  <  .001) in patients with than in those without sepsis. 
As expected, there was a stepwise increase in ICU and hospi-
tal mortality rates according to the severity of sepsis (Table 3). 
Table 1. Characteristics of the Study Cohort on Admission to the ICU According to the Presence of Sepsisa
Characteristics
All Patients
N = 10069
No Sepsis
N = 7096
Sepsis
N = 2973 P Value
Age, years, mean ± SD 60.0 ± 18.0 59.4 ± 18.4 61.5 ± 17.0 <.001
Male, n (%) 5973 (60.1) 4177 (59.7) 1796 (61.0) .21
Severity scores, mean ± SD
 SAPS II score 40.2 ± 18.2 36.4 ± 17.4 49.2 ± 16.6 <.001
 SOFA score 5 [3–9] 4 [2–7] 8 [6–11] <.001
Type of admission, n (%) <.001
 Surgical 3432 (36.0) 2475 (37.0) 957 (33.7)
 Medical 5382 (56.5) 3646 (54.6) 1736 (61.1)
 Trauma 643 (6.8) 512 (7.7) 131 (4.6)
 Other 66 (0.7) 49 (.7) 17 (.6)
Source of admission, n (%) <.001
 ER/ambulance 3814 (37.9) 2780 (39.2) 1034 (34.8)
 Hospital floor 2625 (26.1) 1664 (23.4) 961 (32.3)
 OR/recovery 1811 (18.0) 1363 (19.2) 448 (15.1)
 Other hospital 981 (9.7) 652 (9.2) 329 (11.1)
 Other 838 (8.3) 637 (9.0) 201 (6.8)
Comorbidities, n (%)
 COPD 1240 (12.3) 788 (11.1) 452 (15.2) <.001
 Cancer 1049 (10.4) 710 (10.0) 339 (11.4) .04
 Diabetes mellitus, insulin-dependent 972 (9.7) 664 (9.4) 308 (10.4) .12
 Heart failure, NYHA III/IV 921 (9.1) 588 (8.3) 333 (11.2) <.001
 Chronic renal failure 912 (9.1) 582 (8.2) 330 (11.1) <.001
 Cirrhosis 349 (3.5) 217 (3.1) 132 (4.4) <.001
 Immunosuppression 346 (3.4) 177 (2.5) 169 (5.7) <.001
 Metastatic cancer 332 (3.3) 221 (3.1) 111 (3.7) .11
 Haematologic cancer 212 (2.1) 99 (1.4) 113 (3.8) <.001
 HIV infection 71 (.7) 37 (.5) 34 (1.1) <.001
Number of comorbidities, n (%) <.001
 None 5512 (54.7) 4145 (58.4) 1367 (46.0)
 1 2800 (27.8) 1880 (26.5) 920 (30.9)
 2 1207 (12.0) 740 (10.4) 467 (15.7)
 3 416 (4.1) 249 (3.5) 167 (5.6)
 ≥4 134 (1.3) 82 (1.2) 52 (1.7)
Procedures, n (%)
 Mechanical ventilation 4776 (47.4) 2755 (38.8) 2021 (68.0) <.001
 Renal replacement therapy 537 (5.3) 264 (3.7) 273 (9.2) <.001
Antimicrobials, n (%) 5975 (59.3) 3002 (42.3) 2973 (100) <.001
 Antibiotic 5935 (58.9) 2979 (42.0) 2956 (99.4) <.001
 Antifungal 784 (7.8) 202 (2.8) 582 (19.6) <.001
 Antiviral 273 (2.7) 80 (1.1) 193 (6.5) <.001
Abbreviations: COPD, chronic obstructive pulmonary disease; ER, emergency room; HIV, human immunodeficiency virus; ICU, intensive care unit; NYHA, New York Heart Association 
Classification; OR, operating room; SAPS, simplified acute physiology; SOFA, sequential organ assessment; SD, standard deviation.
aValid percentages are given after exclusion of missing values (data missing from 546 patients for type of admission). 
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Although patients with ICU-acquired sepsis had longer ICU 
stays than those who had sepsis within 48 hours of admission 
to the ICU, they did not have higher mortality rates (Table 3).
The crude risk of in-hospital death was higher in patients 
with infections caused by Pseudomonas spp, Acinetobacter spp, 
and fungi (Table 4). In the multilevel analysis, independent risk 
factors for in-hospital death in patients with sepsis were older 
age, higher SAPS II score, cirrhosis, metastatic cancer, chronic 
heart failure (NYHA III/IV), use of mechanical ventilation or 
renal replacement therapy at any time during the ICU stay, and 
Table 4. Outcome According to Isolated Microorganisms in Patients With Sepsis (n = 2973)
Risk Factor
ICU Mortality,
n (%) Hospital Mortality, n (%)
Crude Risk of In- Hospital Death
OR (95% CI) P Value
Gram-positive 267 (26.2) 360 (36.0) 1.05 (0.89–1.23) .55
 Staphylococcus aureus methicillin sensitive 71 (28.0) 89 (36.0) 1.04 (0.79–1.36) .80
 MRSA 36 (24.2) 51 (34.7) 0.97 (0.69–1.38) .87
 Staphylococcus, coagulase negative 129 (26.0) 184 (37.9) 1.14 (0.93–1.40) .20
 Streptococcus, D group 16 (19.3) 22 (27.5) 0.69 (0.42–1.13) .14
 Streptococcus, others 57 (26.1) 77 (35.8) 1.02 (0.77–1.37) .87
 Other Gram-positive cocci 9 (19.6) 13 (29.5) 0.77 (0.40–1.47) .42
Gram negative 364 (26.6) 492 (37.0) 1.15 (0.99–1.34) .07
 Escherichia coli 114 (24.7) 162 (36.0) 1.04 (0.84–1.28) .74
 Enterobacter spp 45 (24.1) 67 (36.8) 1.07 (0.79–1.46) .66
 Klebsiella spp 92 (26.4) 128 (37.9) 1.13 (0.90–1.43) .29
 Acinetobacter spp 88 (37.0) 110 (48.0) 1.78 (1.36–2.33) <.01
 Proteus spp 28 (23.1) 40 (33.6) 0.92 (0.63–1.36) .69
 Pseudomonas spp 100 (30.1) 131 (40.4) 1.28 (1.01–1.62) .04
 Gram negative, others 82 (25.9) 110 (35.7) 1.02 (0.80–1.31) .87
Anaerobes 23 (29.1) 31 (39.7) 1.22 (0.77–1.93) .41
Other bacteria 6 (33.3) 7 (38.9) 1.17 (0.45–3.02) .75
Fungi 77 (29.2) 107 (41.6) 1.34 (1.04–1.75) .03
 Candida albicans 49 (26.8) 71 (39.9) 1.23 (0.90–1.68) .19
 Candida non-albicans 26 (29.2) 38 (43.7) 1.44 (0.93–2.21) .10
 Fungi, others 16 (36.4) 20 (45.5) 1.54 (0.85–2.80) .16
Viruses and parasites 16 (28.1) 21 (36.8) 1.07 (0.62–1.84) .81
Abbreviations: CI, confidence interval; ICU, intensive care unit; MRSA, methicillin-resistant Staphylococcus aureus; OR, odds ratio.
Table 3. Severity Scores on Admission to the ICU, Maximum Number of Organ Failure, and Mortality Rates According to Sepsis Status
n
Severity Scores, Mean ± SD
ICU LOSa,
Median [IQR]
No. of Organ 
Failures
Median [IQR]
Mortality Rates, % (95% CI)
Category ICUb In-HospitalcSAPS II SOFA
Onset of Sepsis
 Within the first 48 hoursd 2209 50.5 ± 16.8 9.2 ± 3.9 5 [2–10] 3 [2–4] 26.0 (24.2–27.9) 35.8 (33.8–37.9)
 Later 764 45.4 ± 15.5e 7.5 ± 3.8e 12 [6–19]e 3 [2–4] 25.1 (22.0–28.3) 33.8 (30.3–37.2)
Severity of Sepsis on ICU 
Admission
 No sepsisd 8261 37.8 ± 17.5 5.3 ± 4.1 3 [1–5] 1 [0–2] 13.6 (12.9–14.4) 19.0 (18.1–19.9)
 Sepsis without shock 822 46.2 ± 15.4e 7.4 ± 2.9e 5 [2–9]e 2 [1–3]e 20.1 (17.4–22.9)e 30.3 (27.1–33.6)e
 Septic shock 986 55.1 ± 17.2e 11.3 ± 3.6e 5 [2–11]e 3 [2–4]e 33.7 (30.7–36.7)e 43.0 (39.9–46.2)e
Severity of Sepsis During 
ICU Stay
 No sepsisd 7096 36.4 ± 17.4 4.9 ± 4.0 2 [1–4] 1 [0–2] 12.1 (11.3–12.8) 16.7 (15.8–17.6)
 Sepsis without shock 1292 44.6 ± 15.3e 7.0 ± 3.2e 6 [3–11]e 2 [1–3]e 14.3 (12.4–16.2)f 23.6 (21.3–26.0)e
 Septic shock 1681 52.7 ± 16.7e 10.1 ± 3.9e 7 [3–14]e 3 [2–4]e 34.6 (32.3–36.9)e 44.2 (41.7–46.6)e
Abbreviations: CI, confidence interval; ICU, intensive care unit; IQR, interquartile; LOS, length of stay; SAPS, simplified acute physiology score; SD, standard deviation; SOFA, sequential 
organ failure assessment score.
Missing observations: a489, b401, c797. 
dThe reference group.
eP < .01 among groups.
fP < .05 among groups.
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infection with Acinetobacter spp (Supplementary Table E4). 
The use of mechanical ventilation and presence of comorbid 
cirrhosis more than doubled the risk of death. The relative risk 
of death was higher in patients admitted to ICUs in countries 
with upper middle GNI than in those with high GNI (1.77 
[1.31–2.39], P < .001). However, although the model suggested 
significant between-hospital variation (var = 0.28, P = .001) in 
the individual risk of in-hospital death, the between-country 
variation was not significant.
DISCUSSION
The present audit confirms the considerable burden that sepsis 
presents in modern ICUs. This large study, including more than 
10 000 patients from 730 ICUs, indicates that approximately 
30% of all ICU patients have sepsis, as defined by the presence 
of infection and organ dysfunction. This percentage is identi-
cal to that (29.5%) reported in the earlier Sepsis Occurrence in 
Acutely Ill Patients (SOAP) study [1], a large European study 
that used the same methodology, and in a recent analysis of a 
large United Kingdom database [18], but somewhat higher than 
in some other large studies [4, 5, 19, 20]. In addition to pos-
sible differences associated with different definitions of sepsis 
used in the various studies, 2 other major elements may account 
for these apparent inconsistencies. First, we did not include all 
patients admitted to the ICU, but only critically ill patients, 
excluding patients admitted to the ICU for postoperative sur-
veillance without complications. Second, some studies focused 
on admission data [20]; if we consider only the patients who 
had sepsis on admission in our study, the rate of sepsis was 18%. 
More importantly, the percentage of ICU patients with sepsis 
varied around the globe, with particularly high rates in East and 
Southeast Asia, confirming the high disease burden in this area 
[21, 22]. Although these data were collected in 2012, we believe 
they are still relevant, especially given the general lack of global 
data in this regard.
A strength of the present study compared with studies assess-
ing only sepsis on admission or prevalence studies (eg, EPIC II 
[2]) is that patients were followed throughout the ICU course, 
enabling evaluation of sepsis that developed during the ICU stay 
as well as sepsis present on admission. It is interesting to note 
that patients with ICU-acquired sepsis had similar outcomes to 
those of patients with sepsis on admission, and ICU-acquired 
sepsis was not independently associated with a higher risk of 
mortality after adjusting for confounders in the multilevel ana-
lysis. Although we were unable to assess this specifically, van 
Vught et al [23] recently reported a low attributable mortality of 
ICU-acquired infections. Shankar-Hari et al [24] reported that 
the inferred causal link between sepsis and long-term mortality 
was significantly confounded by age, comorbidity, and prea-
cute illness trajectory. More importantly, in our multivariable 
regression analysis, all the above-mentioned factors were found 
to be significant determinants of mortality, suggesting that 
ICU-acquired sepsis may not on its own be a causative factor 
for mortality. Nevertheless, nosocomial infections are responsi-
ble for prolonged stays in the ICU and increased costs [25, 26].
Positive isolates were obtained in 70% of the patients with 
sepsis, a similar finding to that reported in other studies [1, 
19, 27, 28]. Two thirds of these patients had Gram-negative 
organisms isolated and one half had Gram-positive organ-
isms isolated. The most common Gram-negative microorgan-
isms recovered were E coli, Klebsiella spp, Pseudomonas spp, 
and Acinetobacter spp, as in previous studies [1, 27, 28]. It is 
interesting to note that Gram-positive organisms were more 
common in North America than in other parts of the world; 
MRSA was also more common in North America than in other 
parts of the world except the Middle East. These findings are 
important when using guidelines for management of infec-
tion and sepsis, because guidelines developed in one part of 
the world, for example North America, may not be relevant to 
other areas. The results also underline the ongoing importance 
of fungal infections, which were involved in 13% of cases of 
sepsis overall, although the frequency was lower in the United 
States (5%), perhaps because more stringent criteria are used to 
characterize fungal infections in the United States. Finally it is 
noteworthy that approximately 42% of patients without sepsis 
received antimicrobial agents. The reasons for this are unclear, 
but antimicrobials may still be prescribed despite sepsis resolu-
tion or exclusion. In a retrospective analysis of 269 patients who 
were diagnosed with suspected sepsis in the emergency depart-
ment and started on antibiotic therapy, 29% of the patients were 
found not to have bacterial disease, but the median duration of 
antibiotics in these patients was still 7 days (IQR, 4–10) [29].
Intensive care unit mortality rates in patients with sepsis were 
approximately 26% and were twice as high as those in nonsep-
tic patients. This percentage is lower than the 32% observed in 
the SOAP study (using their “severe sepsis” definition that is 
equivalent to our current definition of sepsis) [1] and in other 
studies [1, 19, 27, 28]. Intensive care unit mortality rates in 
patients with septic shock were approximately 35%, a percent-
age that is also lower than that reported in earlier studies [1, 5]. 
Increased awareness of sepsis diagnosis and improved early 
management may have contributed to improved outcomes over 
time. Mortality rates varied around the globe, but in multivaria-
ble analysis, the between-country variation was not significant. 
These findings are in contrast to those from the International 
Multicenter Prevalence Study on Sepsis (IMPreSS) study of 
1794 patients with sepsis from 62 countries, in which mortality 
rates were higher in East Europe and Central/South America 
compared with North America after adjustment for adjusted 
for ICU admission, sepsis status, location of diagnosis, origin of 
sepsis, APACHE II score, and country [30].
As expected, nonsurvivors were older and had more comor-
bidities. As in previous ICU studies [1, 2], Pseudomonas and 
fungal infections were associated with worse outcomes, 
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although only Acinetobacter infection was an independent pre-
dictor for hospital death in the multilevel analysis. More impor-
tantly, our data do not infer a cause-effect relationship, and the 
presence of Acinetobacter may simply be a marker of severity. In 
a systematic review of 6 matched case-control and cohort stud-
ies, Falagas et al [31] reported that Acinetobacter infection was 
associated with increased attributable mortality, although oth-
ers have suggested no independent link between Acinetobacter 
infection and increased risk of death [32].
Mechanical ventilation at any time during the ICU stay 
and pre-existing liver cirrhosis were also important prognos-
tic factors, more than doubling the risk of death. Use of renal 
replacement therapy at any time during the ICU stay was also 
associated with increased mortality. We also identified signif-
icant between-center variation, suggesting that differences in 
local ICU organization may have an impact on outcomes of 
patients with sepsis. Some of the potential factors associated 
with between-center outcomes differences have been identi-
fied in the literature. In an international cohort of 13 796 ICU 
patients, Sakr et al [33] reported that a high nurse/patient ratio 
was independently associated with a lower risk of in-hospital 
death. Gaieski et  al [34] reported that sepsis outcomes were 
improved in centers with higher sepsis case volumes. In a mul-
ticenter study in Canada, Yergens et al [35] reported that ICU 
occupancy >90% was associated with an increase in hospital 
mortality in patients with sepsis admitted from the emergency 
department. We are unable to identify which particular organ-
izational factors may have influenced outcomes from our data, 
and this is an area that needs further study.
Our database was very large, including considerable data on 
demographics, organ function, and outcomes. Nevertheless, 
to successfully collect a large amount of data in many ICUs 
requires some limitations in the level of detail of the collected 
data; therefore, we did not collect precise information on all 
subtypes of microorganisms or their resistance patterns or on 
the appropriateness of antimicrobial coverage. Moreover, data 
were collected by ICU doctors or research nurses who may 
not have specific expertise in infectious diseases, although 
the significance of this is uncertain. Our study has other lim-
itations. First, although the audit included a large number of 
ICUs, the purely voluntary nature of the participation may 
have an impact on the representativeness of the data. Second, 
data collection was not monitored so small errors could not 
be corrected; only obvious incongruous data were verified. 
Third, in some countries, identification of microorganisms 
may have been incomplete because of the limited availability 
of microbiological testing. Moreover, the quality of the anti-
microbials used in the treatment of infection has also been 
questioned in low-resource countries [36]. Fourth, there was 
no means of differentiating between colonization and infec-
tion for some organisms, including Acinetobacter and coagu-
lase-negative staphylococci. Therefore, microorganisms were 
weighted equally in the multilevel analysis. The absence of 
comparative large epidemiologic data that address this issue 
makes it difficult to judge whether the estimates of microor-
ganisms provided in our study overestimate the frequency of 
these infections. Fifth, data were collected for the same period 
in all regions and therefore do not take into account any pos-
sible influence of seasonal variation. Sixth, we did not use the 
exact recent Sepsis-3 definitions [37], which were published 
after our study, partly because we had no data on the evolu-
tion of SOFA scores before ICU admission and blood lactate 
levels were not available in all patients. Nevertheless, we used 
a definition based on the presence of organ dysfunction, a key 
feature of Sepsis-3. Finally, despite adjusting for a large number 
of variables that may influence outcome, the results of the mul-
tilevel analysis could not take into account other unmeasured 
variables that may have been of potential significance.
CONCLUSIONS
Sepsis, as defined by infection with organ dysfunction, remains 
a major health problem in ICU patients worldwide, associated 
with high mortality. There is wide variation in sepsis rates, 
causative microorganisms, and outcome in ICU patients around 
the world. A history of liver cirrhosis or metastatic cancer, use 
of mechanical ventilation or renal replacement therapy, and 
Acinetobacter infection were independently associated with an 
increased risk of in-hospital death. Global epidemiological data 
such as these help increase awareness of sepsis and provide cru-
cial information for future healthcare planning. Further studies 
in this field should be done on a regular basis with standardized 
methodology to ensure the comparability of the results.
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